Insulin glargine 300 units/mL: A new basal insulin product for diabetes mellitus
Author:
Affiliation:
1. Department of Pharmacy Practice, Presbyterian College School of Pharmacy, Clinton, SC
2. Presbyterian College School of Pharmacy, Clinton, SC
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/73/6/359/28334835/ajhp0359.pdf
Reference26 articles.
1. Centers for Disease Control and Prevention. Diabetes report card, 2012. www.cdc.gov/diabetes/pubs/pdf/DiabetesReportCard.pdf (accessed 2014 Dec 16).
2. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion and intensified conventional insulin therapy;Rizza;N Engl J Med,1980
3. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2015
4. AACE/ACE comprehensive diabetes management algorithm;Garber;Endocr Pract,2015
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Tolerability of Insulin Degludec Versus Other Long-acting Basal Insulin Analogues in the Treatment of Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis;Clinical Therapeutics;2022-11
2. A comprehensive stability assessment of insulin degludec using New customized validated RP-HPLC and SEC-HPLC methods in an orthogonal testing protocol;Journal of Pharmaceutical and Biomedical Analysis;2021-09
3. A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial;Diabetes Care;2020-04-09
4. Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3);Diabetes, Obesity and Metabolism;2019-07-18
5. Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study;Diabetes, Obesity and Metabolism;2019-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3